Literature DB >> 32683534

Regulation of histone deacetylase activities and functions by phosphorylation and its physiological relevance.

Sonali Bahl1, Edward Seto2.   

Abstract

Histone deacetylases (HDACs) are conserved enzymes that regulate many cellular processes by catalyzing the removal of acetyl groups from lysine residues on histones and non-histone proteins. As appropriate for proteins that occupy such an essential biological role, HDAC activities and functions are in turn highly regulated. Overwhelming evidence suggests that the dysregulation of HDACs plays a major role in many human diseases. The regulation of HDACs is achieved by multiple different mechanisms, including posttranslational modifications. One of the most common posttranslational modifications on HDACs is reversible phosphorylation. Many HDAC phosphorylations are context-dependent, occurring in specific tissues or as a consequence of certain stimuli. Additionally, whereas phosphorylation can regulate some HDACs in a non-specific manner, many HDAC phosphorylations result in specific consequences. Although some of these modifications support normal HDAC function, aberrations can contribute to disease development. Here we review and critically evaluate how reversible phosphorylation activates or deactivates HDACs and, thereby, regulates their many functions under various cellular and physiological contexts.

Entities:  

Keywords:  Cell signaling; Epigenetics; Histone deacetylase; Phosphorylation

Mesh:

Substances:

Year:  2020        PMID: 32683534      PMCID: PMC7854769          DOI: 10.1007/s00018-020-03599-4

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  166 in total

1.  Differentiated Alzheimer's disease transmitochondrial cybrid cell lines exhibit reduced organelle movement.

Authors:  Patricia A Trimmer; M Kathleen Borland
Journal:  Antioxid Redox Signal       Date:  2005 Sep-Oct       Impact factor: 8.401

2.  Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance.

Authors:  Kenta Masui; Kazuhiro Tanaka; Shiro Ikegami; Genaro R Villa; Huijun Yang; William H Yong; Timothy F Cloughesy; Kanato Yamagata; Nobutaka Arai; Webster K Cavenee; Paul S Mischel
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

Review 3.  Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders.

Authors:  Katrina J Falkenberg; Ricky W Johnstone
Journal:  Nat Rev Drug Discov       Date:  2014-08-18       Impact factor: 84.694

Review 4.  Role of tyrosine kinase inhibitors in cancer therapy.

Authors:  Amit Arora; Eric M Scholar
Journal:  J Pharmacol Exp Ther       Date:  2005-07-07       Impact factor: 4.030

5.  Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC.

Authors:  L Chen; H Hahn; G Wu; C H Chen; T Liron; D Schechtman; G Cavallaro; L Banci; Y Guo; R Bolli; G W Dorn; D Mochly-Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

6.  The tumor suppressor kinase LKB1 activates the downstream kinases SIK2 and SIK3 to stimulate nuclear export of class IIa histone deacetylases.

Authors:  Donald R Walkinshaw; Ryan Weist; Go-Woon Kim; Linya You; Lin Xiao; Jianyun Nie; Cathy S Li; Songping Zhao; Minghong Xu; Xiang-Jiao Yang
Journal:  J Biol Chem       Date:  2013-02-07       Impact factor: 5.157

7.  Lysine glutarylation is a protein posttranslational modification regulated by SIRT5.

Authors:  Minjia Tan; Chao Peng; Kristin A Anderson; Peter Chhoy; Zhongyu Xie; Lunzhi Dai; Jeongsoon Park; Yue Chen; He Huang; Yi Zhang; Jennifer Ro; Gregory R Wagner; Michelle F Green; Andreas S Madsen; Jessica Schmiesing; Brett S Peterson; Guofeng Xu; Olga R Ilkayeva; Michael J Muehlbauer; Thomas Braulke; Chris Mühlhausen; Donald S Backos; Christian A Olsen; Peter J McGuire; Scott D Pletcher; David B Lombard; Matthew D Hirschey; Yingming Zhao
Journal:  Cell Metab       Date:  2014-04-01       Impact factor: 27.287

Review 8.  Regulating the regulators: the post-translational code of class I HDAC1 and HDAC2.

Authors:  Chiara V Segré; Susanna Chiocca
Journal:  J Biomed Biotechnol       Date:  2010-12-09

9.  PHOSIDA (phosphorylation site database): management, structural and evolutionary investigation, and prediction of phosphosites.

Authors:  Florian Gnad; Shubin Ren; Juergen Cox; Jesper V Olsen; Boris Macek; Mario Oroshi; Matthias Mann
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

10.  The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility.

Authors:  Ruwin Pandithage; Richard Lilischkis; Kai Harting; Alexandra Wolf; Britta Jedamzik; Juliane Lüscher-Firzlaff; Jörg Vervoorts; Edwin Lasonder; Elisabeth Kremmer; Bernd Knöll; Bernhard Lüscher
Journal:  J Cell Biol       Date:  2008-03-10       Impact factor: 10.539

View more
  7 in total

1.  Trichostatin A enhances radiosensitivity and radiation-induced DNA damage of esophageal cancer cells.

Authors:  Shaobo Wang; Min Song; Bo Zhang
Journal:  J Gastrointest Oncol       Date:  2021-10

2.  Histone deacetylase 5 is a phosphorylation substrate of protein kinase D in osteoclasts.

Authors:  Carina Mello Guimaraes Meyers; Samuel D Burciaga; Bora Faulkner; Parandis Kazemi; Jacob M Cohn; Kim C Mansky; Eric D Jensen
Journal:  Bone       Date:  2022-03-19       Impact factor: 4.626

3.  Characterization of Acetylation of Histone H3 at Lysine 9 in the Trigeminal Ganglion of a Rat Trigeminal Neuralgia Model.

Authors:  Wenbin Wei; Yuemin Liu; Yating Qiu; Minjie Chen; Yiwen Wang; Zixiang Han; Ying Chai
Journal:  Oxid Med Cell Longev       Date:  2022-05-04       Impact factor: 7.310

Review 4.  Lessons in Organic Fluorescent Probe Discovery.

Authors:  Sachin B Wagh; Vladimir A Maslivetc; James J La Clair; Alexander Kornienko
Journal:  Chembiochem       Date:  2021-06-23       Impact factor: 3.164

5.  Arabidopsis SUMO E3 Ligase SIZ1 Interacts with HDA6 and Negatively Regulates HDA6 Function during Flowering.

Authors:  Sujuan Gao; Xueqin Zeng; Jianhao Wang; Yingchao Xu; Chunwei Yu; Yishui Huang; Feng Wang; Keqiang Wu; Songguang Yang
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

Review 6.  Regulatory Effects of Histone Deacetylase Inhibitors on Myeloid-Derived Suppressor Cells.

Authors:  Yudan Cui; Jingshan Cai; Wenxin Wang; Shengjun Wang
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

7.  PP2A and cancer epigenetics: a therapeutic opportunity waiting to happen.

Authors:  Samantha L Tinsley; Brittany L Allen-Petersen
Journal:  NAR Cancer       Date:  2022-02-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.